Niu M T, Jermano J A, Reichelderfer P, Schnittman S M
Medical Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892.
AIDS Res Hum Retroviruses. 1993 Sep;9(9):913-24. doi: 10.1089/aid.1993.9.913.
A Workshop on primary human immunodeficiency virus type 1 (HIV-1) infection sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the Office of AIDS Research (OAR) of the National Institutes of Health (NIH) was held February 25-26, 1993 in Bethesda, Maryland. The major goals of this scientific meeting were to bring together researchers and infectious disease specialists who have expertise in primary HIV-1 infection (PHI) to review the pathogenesis of PHI, the treatment experience of PHI in humans and of early retroviral infection in animal models, and to devise theoretical and operational strategies for future clinical trials relating to therapeutic intervention of PHI. The proceedings of this workshop are timely and serve to further the development of innovative strategies for the treatment of HIV-1 infection.
由美国国立卫生研究院（NIH）下属的国立过敏与传染病研究所（NIAID）及艾滋病研究办公室（OAR）主办的关于原发性人类免疫缺陷病毒1型（HIV-1）感染的研讨会于1993年2月25日至26日在马里兰州贝塞斯达举行。本次科学会议的主要目标是召集在原发性HIV-1感染（PHI）方面具有专业知识的研究人员和传染病专家，以回顾PHI的发病机制、人类PHI的治疗经验以及动物模型中早期逆转录病毒感染的治疗经验，并为未来与PHI治疗干预相关的临床试验制定理论和操作策略。本次研讨会的会议记录很及时，有助于推动治疗HIV-1感染创新策略的发展。
